Merck Serono’s Liquid Biopsy Test For Metastatic Colorectal Cancer To Hit Market In 2016
This article was originally published in Clinica
Executive Summary
Merck Serono’s collaboration with Sysmex Inostics will soon bear fruit with the European launch of a liquid biopsy test for metastatic colorectal cancer based on Sysmex’ OncoBEAM RAS digital polymerase chain reaction (PCR) assay.